C85.27
Mediastinal (thymic) large B-cell lymphoma, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Mediastinal (thymic) large B-cell lymphoma with spleen involvement is a rare type of non-Hodgkin lymphoma that originates in the thymus gland located in the mediastinum, a central part of the chest. It is characterized by the abnormal growth of large B-cells, a type of white blood cell vital to the immune system. When this lymphoma spreads to the spleen, it can affect immune function and cause various health issues. Understanding this condition involves exploring its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to uncontrolled B-cell growth Immunodeficiency conditions that impair the body's ability to detect and destroy abnormal cells Environmental factors such as exposure to certain chemicals or radiation Infections, especially those involving viruses like Epstein-Barr virus (EBV), which have been linked to some lymphomas Age-related changes, as lymphomas are more common in middle-aged and older adults
Key Symptoms: Persistent swelling or lumps in the chest or neck area Unexplained weight loss Night sweats and fever Shortness of breath or coughing due to pressure on the lungs or airways Pain or discomfort in the chest area Swelling or tenderness in the abdomen, which may relate to spleen involvement Fatigue and general feelings of weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosis of mediastinal large B-cell lymphoma with spleen involvement involves several steps:
Treatment Protocols: Treatment options usually involve a combination of approaches tailored to the patient's specific condition:
Clinical Advice & FAQs
Billing Guidance
Is C85.27 a billable ICD-10 code?
Yes, C85.27 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.27?
Clinical documentation must specify the nature of Mediastinal (thymic) large B-cell lymphoma, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
